HER-2 B Cell Peptide Vaccine

NCT06414733 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Metastatic Gastrointestinal Carcinoma
HER2-positive Breast Cancer
HER2-positive Gastric Cancer
EGFR Overexpression

Interventions

BIOLOGICAL: Combination of MVF-HER-2 (597-626) and MVF-HER-2 (266-296) emulsified with ISA 720

Sponsor

Pravin T.P Kaumaya